Therapeutic Monoclonal Antibodies for Migraine | Touch Neurology | Independent Insight for Medical Specialists | NeuroImmunology | Scoop.it
From www.touchneurology.com - April 13, 2015 1:31 PM
Monoclonal antibody (mAb) treatment has revolutionized the approach to many diseases and represents a fast-growing area of drug development.1,2 They are composed of immunoglobulin G (IgG) isotypes, divided into four subclasses.3 In 1986, the US...

Via Krishan Maggon